A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors C. Massard et al, 2022, Cancer Chemotherapy and Pharmacology CrossRef
A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth Uttara Saran et al, 2023, Frontiers in Pharmacology CrossRef
Moving Breast Cancer Therapy up a Notch Erik W. J. Mollen et al, 2018, Frontiers in Oncology CrossRef
Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23 Patrick L. Mulcrone et al, 2020, Scientific Reports CrossRef
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives Nadezda Zhdanovskaya et al, 2021, Cancers CrossRef
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer Inna P. Ganshina et al, 2021, Journal of Modern Oncology CrossRef
Use of nanocellulose in the intracellular delivery of biological and non-biological drugs: a review Navinchandra V. Puppala et al, 2023, Cellulose CrossRef
Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells
Xiang Wen Yuan et al, 2020, Cancer Management and Research CrossRef
Notch Signalling in Breast Development and Cancer Abigail Edwards et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications Inês Conde et al, 2022, Cells CrossRef
Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer Feng Su et al, 2016, Oncotarget CrossRef